Biopharma Outsourcing Companies

Labcorp is a provider of laboratory tests for physicians. It specializes in providing physicians with laboratory tests. They develop new tests that provide enhanced accuracy and additional clinical information. Their customers include physicians and their patients, hospitals and managed care plans, private employers, military and law enforcement agencies, and pharmaceutical and biotechnology companies. Services offered range from routine testing such as basic blood counts and cholesterol tests to highly complex methods that assist in diagnosing genetic conditions, cancer, and other rare diseases. In 2022, the company recorded annual revenues of $14.76B and a net profit of $1B.

Pharmaceutical and biotechnology company. It focus on active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs, and agro chemicals. It manufactures generic APIs with a special focus on antiretrovirals and hepatitis. The company also manufactures APIs for oncology, cardiovascular, and anti-diabetic therapeutic segments. It also manufactures specialty ingredients for use in nutraceuticals, dietary supplements, and cosmeceutical products.

WuXi AppTec is a provider of a suite of CRO and CDMO services for small molecules, biologics, and medical devices. It offers a suite of services for the research, development, and manufacturing of both small molecules and biologics and also caters to medical device development and has operations all over the globe. They provide a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. The company built its initial capabilities around discovery chemistry and has further enhanced the integrated services with analytical services, bio-analytical services, process research, process development services, API manufacturing services, DMPK/ADME, discovery biology, pharmacology, formulation, toxicology, genomic services, biologics manufacturing services, antibody, and biological research reagent manufacturing and sales, and most recently clinical research and regulatory services. In 2022, the company recorded annual revenues of $5.84B and a net profit of $1.31B.

Developer of integrated contract research development and manufacturing services. The company offers end‑to‑end drug discovery, development and manufacturing support for small molecules, biologics and nutritional actives. It provides medicinal chemistry, process synthesis, analytical R&D, toxicology and GLP preclinical testing under one roof. Services include microbial screening, protein expression, peptide synthesis, antibody drug conjugates and fermentation scale‑up capable from milligram to tonne volumes. The infrastructure includes cGMP kilo‑labs, pilot manufacturing and AAALAC accredited vivarium for in vitro and in vivo studies. Quality control, regulatory compliance and analytical method development are embedded as part of the scientific service portfolio.